Neural Therapeutics, Inc. (NURL.CX)

0.015 0.00 (0.00%) CAD  |  CNSX  |  Jan 19, 16:00
More

Neural Therapeutics Revenue Estimates for Next Quarter

Revenue Estimates for Next Quarter Chart

View Revenue Estimates for Next Quarter for NURL.CX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Quarter Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Revenue Estimates for Next Quarter Range, Past 5 Years

View Revenue Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Quarter Benchmarks

View Revenue Estimates for Next Quarter Benchmarks
Start Trial
BioMark Diagnostics, Inc. --
Justera Health Ltd. --
Wesana Health Holdings, Inc. Upgrade
Biocure Technology, Inc. --
Core One Labs, Inc. --